Tatva Chintan Pharma Chem Limited (NSE:TATVA) — Market Cap & Net Worth
Market Cap & Net Worth: Tatva Chintan Pharma Chem Limited (TATVA)
Tatva Chintan Pharma Chem Limited (NSE:TATVA) has a market capitalization of $331.65 Million (Rs30.67 Billion) as of May 3, 2026. Listed on the NSE stock exchange, this India-based company holds position #14546 globally and #702 in its home market, demonstrating a -0.79% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tatva Chintan Pharma Chem Limited's stock price Rs1311.00 by its total outstanding shares 23392055 (23.39 Million). Analyse how efficiently does Tatva Chintan Pharma Chem Limited generate cash to see how efficiently the company converts income to cash.
Tatva Chintan Pharma Chem Limited Market Cap History: 2021 to 2026
Tatva Chintan Pharma Chem Limited's market capitalization history from 2021 to 2026. Data shows change from $669.11 Million to $331.65 Million (-11.17% CAGR).
Index Memberships
Tatva Chintan Pharma Chem Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MICROCAP 250
NIFTYMICROCAP250
|
$143.76 Billion | 0.23% | #142 of 250 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.20 Trillion | 0.01% | #516 of 750 |
Weight: Tatva Chintan Pharma Chem Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Tatva Chintan Pharma Chem Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tatva Chintan Pharma Chem Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.09x
Tatva Chintan Pharma Chem Limited's market cap is 0.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.91x
Tatva Chintan Pharma Chem Limited's market cap is 5.91 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $669.11 Million | $3.00 Billion | $522.62 Million | 0.22x | 1.28x |
| 2022 | $542.28 Million | $4.34 Billion | $958.74 Million | 0.13x | 0.57x |
| 2023 | $404.39 Million | $4.24 Billion | $454.87 Million | 0.10x | 0.89x |
| 2024 | $225.02 Million | $3.94 Billion | $303.54 Million | 0.06x | 0.74x |
| 2025 | $337.52 Million | $3.83 Billion | $57.13 Million | 0.09x | 5.91x |
Competitor Companies of TATVA by Market Capitalization
Companies near Tatva Chintan Pharma Chem Limited in the global market cap rankings as of May 3, 2026.
Key companies related to Tatva Chintan Pharma Chem Limited by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #91 globally with a market cap of $210.18 Billion USD.
- Air Liquide SA (PA:AI): Ranked #222 globally with a market cap of $108.00 Billion USD ( €92.38 Billion EUR).
- AIR LIQUIDE ADR 1/5/EO 11 (F:AILA): Ranked #232 globally with a market cap of $103.86 Billion USD ( €88.84 Billion EUR).
- Sherwin-Williams Co (NYSE:SHW): Ranked #334 globally with a market cap of $78.83 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Linde plc Ordinary Shares | NASDAQ:LIN | $210.18 Billion | $507.92 |
| #222 | Air Liquide SA | PA:AI | $108.00 Billion | €183.08 |
| #232 | AIR LIQUIDE ADR 1/5/EO 11 | F:AILA | $103.86 Billion | €36.60 |
| #334 | Sherwin-Williams Co | NYSE:SHW | $78.83 Billion | $318.00 |
Tatva Chintan Pharma Chem Limited Historical Marketcap From 2021 to 2026
Between 2021 and today, Tatva Chintan Pharma Chem Limited's market cap moved from $669.11 Million to $ 331.65 Million, with a yearly change of -11.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs331.65 Million | -1.74% |
| 2025 | Rs337.52 Million | +49.99% |
| 2024 | Rs225.02 Million | -44.35% |
| 2023 | Rs404.39 Million | -25.43% |
| 2022 | Rs542.28 Million | -18.95% |
| 2021 | Rs669.11 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Tatva Chintan Pharma Chem Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $331.65 Million USD |
| MoneyControl | $331.65 Million USD |
| MarketWatch | $331.65 Million USD |
| marketcap.company | $331.65 Million USD |
| Reuters | $331.65 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and br… Read more